Surprisingly, neither NAIP silencing nor further inhibiting NLRP3 with MCC950 treatment affected caspase‐1 activation (Figure S3C) or pyroptosis (Figure S3D) during infection with SPtA 9150. This evidence concerns the gene NLRP3 and infection.